Summary
Medtronic plc (MDT) has filed a Form 8-K on November 18, 2025, to report its second quarter fiscal year 2026 financial results. The filing primarily consists of a press release containing these results, which is furnished as an exhibit. Investors should refer to the accompanying press release (Exhibit 99.1) for the detailed financial performance and operational highlights for the quarter ended November 17, 2025. While the 8-K itself does not provide the specific financial figures, it serves as the official notification of the release of this important information. Key metrics such as revenue, earnings per share (EPS), and segment performance, along with management's commentary on business outlook and strategic progress, will be found within the press release. Investors are encouraged to review this document thoroughly to understand Medtronic's current financial health and future prospects.
Key Highlights
- 1Medtronic plc filed an 8-K on November 18, 2025.
- 2The filing announces the company's second quarter fiscal year 2026 financial results.
- 3The detailed financial results are provided in a press release, furnished as Exhibit 99.1.
- 4The event date for the financial results announcement was November 17, 2025.
- 5Investors should consult the press release for specific financial performance data.
- 6The report includes an interactive data file in Inline XBRL format.